Kolexia
Le Roy Florence Gastro-entérologie
Le Roy Florence
Gastro-entérologie
Hôpital du Scorff
Lorient, France
52 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Adénocarcinome Tumeurs du foie Tumeurs colorectales Carcinome hépatocellulaire Hypersensibilité Carcinome à cellules en bague à chaton Asthénie Métastase tumorale

Collaborateurs

Voir plus
Couffon Caroline
Couffon Caroline
Hôpital du Scorff, Lorient, France
Zoheir Yasmina
Zoheir Yasmina
Hôpital du Scorff, Lorient, France
Deniel Marie-Clemence
Deniel Marie-Clemence
Hôpital du Scorff, Lorient, France
Tougeron David
Tougeron David
Hôpital La Miletrie, Poitiers, France

Industries

Voir plus
Servier
5 collaboration(s)
Dernière en 2023
Merck-Serono
2 collaboration(s)
Dernière en 2022
Ipsen
1 collaboration(s)
Dernière en 2021
MSD
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
OSCAR: Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions.
JAMA oncology   21 mars 2023
Metastatic colorectal carcinoma with signet-ring cells: Clinical, histological and molecular description from an Association des Gastro-Entérologues Oncologues (AGEO) French multicenter retrospective cohort.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   09 août 2021
Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohort.
British journal of cancer   26 mars 2021
5-Fluorouracil rechallenge after 5-fluorouracil-induced hyperammonemic encephalopathy.
Anti-cancer drugs   21 septembre 2020
FOLFIRINOX in locally advanced (LA) and borderline resectable (BR) pancreatic adenocarcinoma: Update of the AGEO cohort
Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain   01 octobre 2019
Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study.
Targeted oncology   03 septembre 2019
Implementation of a Nurse-driven Educational Program Improves Management of Sorafenib's Toxicities in Hepatocellular Carcinoma.
Cancer nursing   28 août 2019
Vision loss after chemotherapy: an irinotecan-induced retinopathy.
European journal of cancer (Oxford, England : 1990)   01 avril 2019
Metastatic colorectal signet-ring cell carcinoma: Clinical, histological and molecular description from an AGEO French multicenter retrospective cohort
Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany   01 octobre 2018